[Ip-health] ​Workshop on the History, Experiences, and Prospects of Compulsory Licensing of Medical Patents in the United States

Jamie Love james.love at keionline.org
Thu Feb 16 12:13:48 PST 2017


​This is the current agenda for the Feb 24 workshop on compulsory
licensing.

People who want to attend should register using the link provided here: ​​
http://www.keionline.org/node/2717​.

There will be a webcast of the event via our youtube channel.  Zack's post
a link to that later.

​-------------------------------------​

​​
Workshop on the History, Experiences, and Prospects of Compulsory Licensing
of Medical Patents in the United States

Date: Friday February 24, 2017
Location: Kaiser Permanente Center for Total Health
700 Second St. NE (near Union Station)
Washington, DC 20002

The event will feature presentations and roundtable discussions and
questions and comments from the workshop participants on several topics
relating to the non-voluntary use of patents in the United States, with a
focus on medical patents.


AGENDA - revised  Feb 15

​ ​
9 AM to 10 AM, coffee and registration

10 AM: Introduction
10:15 - 10:45

Review of all U.S. legislation proposed, enacted and/or repealed on the
compulsory licensing of patents from the 19th Century to the present.

Zack Struver, KEI


10:50 - 11:50

A discussion non-voluntary use of patents under 28 USC 1498(a), the statute
that covers use of patents “by or for the United States without license of
the owner.”

Amy Kapczynski, Professor of Law, Yale Law School
Robert Weissman, President, Public Citizen

11:50 AM to 12:30 PM
Lunch

12:30 PM - 1:30 PM
A discussion of the non-voluntary use of patents in court cases involving
requests for permanent injunctions as a remedy to infringement, under the
standards set out in the by the U.S. Supreme Court in eBay Inc. v.
MercExchange, L.L.C., 547 U.S. 388 (2006)
Matthew Herper, Forbes
Rachel Sachs,  Associate Professor at the Washington University in St.
Louis School of Law
Andrew Goldman, Counsel for Policy and Legal Affairs, Knowledge Ecology
International


1:35 PM - 3:00 PM
Discussion of the experience with the Bayh-Dole Act march-in provisions.

Hanna Vogel, Legislative Assistant, Representative Doggett, U.S. House of
Representatives
C. Allen Black, Jr., Ph.D., Adjunct Professor of Law, University of
Pittsburgh School of Law.   (Counsel for Fabrazyme march-in case).
James Love, Knowledge Ecology International (KEI)
Ashley Stevens, President, Focus IP Group  (former President of  AUTM, the
Association of University Technology Managers )


3:00 PM to 3:15 PM

Break

3:15 PM to  3:45 PM
Global norms and compulsory licensing statutes in selected industrialized
countries.

Frederick M. Abbott, Edward Ball Eminent Scholar Professor of International
Law, Florida State University, College of Law
Andrew Goldman, Counsel for Policy and Legal Affairs, Knowledge Ecology
International

3:50 PM to close
Concluding discussion about the need for new statutory authority to grant
compulsory licenses on patents, with references to (a) US government
negotiations on prices of drugs, (b) the broader need to curb excessive
prices of drugs, and (c) the role of compulsory licensing in improving
access to research tools, diagnostic tests, and upstream technologies such
as CRISPR Genome Editing, and for follow-on inventions.

Everyone will be invited to share thoughts, starting with initial comments
from:

Aaron S. Kesselheim, MD, JD, MPH, Associate Professor of Medicine at
Harvard Medical School and a faculty member in the Division of
Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine at
Brigham and Women’s Hospital.  (TBC)
Amy Kapczynski, Professor of Law, Yale Law School
Rachel Sachs, Associate Professor at the Washington University in St. Louis
School of Law
James Love, Knowledge Ecology International
Alex Lawson, Social Security Works
Shanna Devine, Public Citizen


--
James Love.  Knowledge Ecology International
http://www.keionline.org/donate.html
KEI DC tel: +1.202.332.2670, US Mobile: +1.202.361.3040, Geneva Mobile:
+41.76.413.6584, twitter.com/jamie_love



More information about the Ip-health mailing list